Metraipolis › archive › dc_3ebbb2444628

Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind,… — Europe PMC PMID:41212997

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41212997
DOI
10.1161/circulationaha.125.077304
License (as archived)
solo-consultazione
Archived
2026-11-08T17:07:46.809Z
SHA-256 of the archived text
a02fcfec04b68c9648305899d31d5e078950d85e3133070aa915de14532ed32d
Stable URL of this page
https://metraipolis.com/documento/dc_3ebbb2444628

How to cite

Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind,… — Europe PMC PMID:41212997 — Europe PMC (en), https://europepmc.org/article/MED/41212997 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3ebbb2444628 (Metraipolis archive dc_3ebbb2444628, sha256 a02fcfec04b68c9648305899d31d5e078950d85e3133070aa915de14532ed32d)
BibTeX
@misc{dc3ebbb2444628,
  title = {Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind,… — Europe PMC PMID:41212997},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41212997},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3ebbb2444628; sha256 a02fcfec04b68c9648305899d31d5e078950d85e3133070aa915de14532ed32d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41212997. Agents can read the archived copy with the MCP tool read_document.